Typhoid Fever *

Tropical Infectious Diseases

Volumn 1, Issue , 2006, Pages 220-240

  Epstein, Judith E ^a,b,c   Hoffman, Stephen L ^d,e  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d SANARIA INC   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882494241     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06668-9.50022-3     Document Type: Chapter

References (140)

1. Woodward TE, Smadel JE, Ley HL, et al. Preliminary report on the beneficial effect of chloromycetin in the treatment of typhoid fever. Ann Intern Med 1948, 2:131-134.
2. Levine MM, Black RE, Ferreccio C, et al. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1987, 1049-1052.
3. Wahdan MH, Serie C, Cerisier Y, et al. A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: Three-year results. J Infect Dis 1985, 145:292-295.
4. Simanjuntak CH, Paleologo FP, Punjabi NH, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet 1991, 338:1055-1059.
5. Acharya IL, Lowe CU, Thapa R, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N Engl J Med 1987, 317:1101-1104.
6. Klugman KP, Koornhof HJ, Schneerson R, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987, 2:1165-1169.
7. Lin FY, Ho VA, Khiem HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001, 334:1263-1269.
8. Mai NL, Phan VB, Vo AH, et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N Engl J Med 2003, 349:1390-1391.
9. Parkhill J, Dougan G, James KD, et al. Complete genomic sequence of multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 2001, 413:848-852.
10. Koneman EW, Allen SD, Janda WM, et al. The Enterobacteriaceae. Color Atlas and Textbook of Diagnostic Microbiology 1992, 105-184. J.B. Lippincott, Philadelphia. 4th ed.
11. McClelland M, Sanderson KE, Spieth J, et al. The complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 2001, 413:852-856.
12. Blattner FR, Plunkett G, Bloch CA, et al. The complete genome sequence of Escherichia coli K-12. Science 1997, 277:1453-1474.
13. Wain J, House D, Parkhill J, et al. Unlocking the genome of the human typhoid bacillus. Lancet Infect Dis 2002, 2:163-170.
14. Edelman R, Levine MM Summary of an international workshop on typhoid fever. Rev Infect Dis 1986, 8:329-349.
15. Osler W Principles and Practices of Medicine 1909, 57-105. Appleton, New York. 7th ed.
16. Summary of notifiable diseases-United States, 2002. MMWR 2002, 51:70-76. Centers for Disease Control and Prevention.
17. Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children aged less than 5 years. Lancet 1999, 354:734-737.
18. Lin FY, Vo AH, Phan VB, et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg 2000, 62:644-648.
19. Typhoid vaccines. Wkly Epidemiol Rec 2000, 75:257-264.
20. Crump JA, Luby SP, Mintz ED The global burden of typhoid fever. Bull World Health Org 2004, 82:346-353.
21. Rogerson SJ, Spooner VJ, Smith TA, et al. Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg 1991, 85:113-116.
22. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994: Changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998, 158:633-638.
23. Hoffman TA, Ruiz CJ, Counts GW, et al. Waterborne typhoid fever in Dade County, Florida: Clinical and therapeutic evaluations of 105 bacteremic patients. Am J Med 1975, 59:481-487.
24. Typhoid fever-San Antonio, Texas. MMWR 1981, 30:540. 545-546,.
25. Taylor JP, Shandera WX, Betz TG, et al. Typhoid fever in San Antonio, Texas: An outbreak traced to a continuing source. J Infect Dis 1984, 149:553-557.
26. Lin FYC, Becke JM, Groves C Restaurant-associated outbreak of typhoid fever in Maryland: Identification of carrier facilitated by measurement of serum Vi antibodies. J Clin Microbiol 1988, 26:1194-1197.
27. Birkhead GS, Morse DL, Levine WC, et al. Typhoid fever at a resort hotel in New York: A large outbreak with an unusual vehicle. J Infect Dis 1993, 167:1228-1232.
28. Typhoid fever-Skagit County, Washington. MMWR 1990, 39:749-751.
29. Pradier C, Keita-Perse O, Bernard E, et al. Outbreak of typhoid fever on the French Riviera. Eur J Clin Microbiol Infect Dis 2000, 19:464-467.
30. Olsen SJ, Bleasdale SC, Magnano AR, et al. Outbreaks of typhoid fever in the United States, 1960-99. Epidemiol Infect 2003, 130:13-21.
31. Colquhoun J, Weetech RS Resistance to chloramphenicol developing during treatment of typhoid fever. Lancet 1950, 2:621-623.
32. Gupta A Multidrug-resistant typhoid fever in children: Epidemiology and therapeutic approach. Pediatr Infect Dis J 1994, 13:134-140.
33. Mirza SH, Beeching NJ, Hart CA Multi-drug resistant typhoid: A global problem. J Med Microbiol 1996, 44:317-319.
34. Rowe B, Ward LR, Threlfall EJ Multidrug-resistant Salmonella typhi: A worldwide epidemic. Clin Infect Dis 1997, 24(Suppl 1):S106-S109.
35. Alsoub H, Uwaydah AK, Matar I, et al. A clinical comparison of typhoid fever caused by susceptible and multidrug-resistant strains of Salmonella typhi. Br J Clin Pract 1997, 51:8-10.
36. Wain J, Diep TS, Ho VA, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998, 36:1683-1687.
37. Hoa NT, Diep TS, Wain J, et al. Community-acquired septicaemia in southern Viet Nam: The importance of multidrug-resistant Salmonella typhi. Trans R Soc Trop Med Hyg 1998, 92:503-508.
38. Threlfall EJ, Ward LR, Skinner JA, et al. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 1999, 353:1590-1591.
39. Threlfall EJ, Ward LR Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis 2001, 7:448-450.
40. Mermin JH, Vilar R, Carpenter J, et al. A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 1999, 179:1416-1422.
41. Parry C, Wain J, Chinh NT, et al. Quinolone-resistant Salmonella typhi in Vietnam. Lancet 1998, 351:1289.
42. Wain J, Hoa NT, Chinh NT, et al. Quinolone-resistant Salmonella typhi in Viet Nam: Molecular basis and clinical response to treatment. Clin Infect Dis 1997, 25:1404-1410.
43. Mehta G, Randhawa VS, Mohapatra NP Intermediate susceptibility to ciprofloxacin in Salmonella typhi strains in India. Eur J Clin Microbiol Infect Dis 2001, 20:760-761.
44. Saha Sk, Talukder SY, Islam M, et al. A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J 1999, 18:387.
45. Ackers ML, Puhr ND, Tauxe RV, et al. Laboratory-based surveillance of Salmonella serotype typhi infections in the United States: Antimicrobial resistance on the rise. JAMA 2000, 283:2668-2673.
46. Wasfy Mo, French R, Ismail TF, et al. Trends of multiple-drug resistance among Salmonella serotype typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002, 35:1265-1268.
47. Gautam V, Gupta NK, Chaudhary U, et al. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002, 6:281-287.
48. Saha SK, Saha S, Ruhulamin M, et al. Decreasing trends of multi-resistant Salmonella typhi in Bangladesh. J Antimicrob Chemother 1997, 39:554-556.
49. Tjaniadi P, Lesmana M, Subekti D, et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg 2003, 68:666-670.
50. Butler T, Islam A, Kabir I, et al. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: Review of 552 hospitalized patients with diarrhea. Rev Infect Dis 1991, 13:85-90.
51. Duggan MB, Beyer L Enteric fever in young Yoruba children. Arch Dis Child 1975, 50:67-71.
52. Vollaard AM, Ali S, van Asten HA, et al. Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA 2004, 291:2607-2615.
53. Saha SK, Baqui AH, Hanif M, et al. Typhoid fever in Bangladesh: Implications for vaccination policy. Pediatr Infect Dis J 2001, 20(5):521-524.
54. Le Page P, Bogaerts J, Van Goethem C, et al. Community acquired bacteremia in African children. Lancet 1987, 1:1458-1461.
55. Reller ME, Olsen SJ, Kressel AB, et al. Sexual transmission of typhoid fever: A multistate outbreak among men who have sex with men. Clin Infect Dis 2003, 37:141-144.
56. Hornick RB, Greisman SE, Woodward TE, et al. Typhoid fever: Pathogenesis and immunologic control. Part 1. N Engl J Med 1970, 283:686-691.
57. Blaser MJ, Newman LS A review of human salmonellosis: I. Infective dose. Rev Infect Dis 1982, 4:1096-1106.
58. Gorden J, Small PLC Acid resistance in enteric bacteria. Infect Immun 1982, 61:364-367.
59. Dunstan SJ, Stephens HA, Blackwell JM, et al. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis 2001, 183:261-268.
60. Gotuzzo E, Frisancho O, Sanchez J, et al. Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch Intern Med 1991, 151:381-382.
61. Crewe-Brown HH, et al: Invasive Salmonella species and HIV infection. In Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3, 1998, 284 (abstract).
62. Kohtaba S, Yokobata H, Yabuuchi E Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: An ultrastructural study. Microbiol Immunol 1986, 30:1225-1237.
63. Rubin RH, Weinstein L Salmonellosis: Microbiologic, Pathologic, and Clinical Features 1977, Stratton Intercontinental, New York.
64. Bitar R, Tarpley J Intestinal perforation in typhoid fever: A historical and state-of-the-art review. Rev Infect Dis 1985, 7:257-271.
65. Fame TM, Englehard D, Riley HD Hemophagocytosis accompanying typhoid fever. Pediatr Infect Dis 1986, 5:367-369.
66. Hornick RB, Greisman SE, Woodward TE, et al. Typhoid fever: Pathogenesis and immunologic control. Part 2. N Engl J Med 1970, 283:739-746.
67. Greisman SE, Hornick RB, Wagner HN, et al. The role of endotoxin during typhoid fever and tularemia in man: IV. The integrity of the endotoxin tolerance mechanisms during infection. J Clin Invest 1969, 48:613-629.
68. Butler T, Bell WR, Levin J, et al. Typhoid fever: Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med 1978, 138:407-410.
69. Hornick RB, Greisman S On the pathogenesis of typhoid fever. Arch Intern Med 1978, 138:357-359.
70. Forrest BD, LaBrooy LT, Breyer L, et al. The human humoral immune response to Salmonella typhi Ty21a. J Infect Dis 1991, 163:336-345.
71. Levine MM, Ferreccio C, Black RE, et al. Progress in vaccines against typhoid fever. Prev Inf Dis 1989, 11(Suppl 3):S552-S557.
72. Rajagopalan P, Kumar R, Malaviya AN Immunological studies in typhoid fever. I. Immunoglobulins, C3, antibodies, rheumatoid factor and circulation immune complexes in patients with typhoid fever. Clin Exp Immunol 1981, 44:68-73.
73. Thevanesam V, Arseculeraine SC, Weliange LV, et al. Cell mediated and humoral immune responses in human typhoid fever. Trop Geogr Med 1982, 34:13-17.
74. Murphy JR, Wasserman SS, Baqar S, et al. Immunity to Salmonella typhi: Considerations relevant to measurement of cellular immunity in typhoid-endemic regions. Clin Exp Immunol 1989, 75:228-233.
75. Mabel TJ, Paniker CKJ The role of cell-mediated immunity in typhoid. Asian J Infect Dis 1979, 3:69-75.
76. Tagliabue A, Villa L, De Magistris MT, et al. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. J Immunol 1986, 137:1504-1510.
77. Stuart BM, Pullen RL Typhoid: Clinical analysis of three hundred and sixty cases. Arch Intern Med 1946, 78:629-661.
78. Klotz SA, Jorgensen JH, Buckwold FJ, et al. Typhoid fever. An epidemic with remarkably few clinical signs and symptoms. Arch Intern Med 1984, 144:533-537.
79. Eustache J-M, Kreis DJ Typhoid perforation of the intestine. Arch Surg 1983, 118:1269-1271.
80. Meier DE, Imediegwu OO, Tarpley JL Perforated typhoid enteritis: Operative experience with 108 cases. Am J Surg 1989, 157:423-427.
81. Kim J-P, Oh S-K, Jarrett F Management of ileal perforation due to typhoid fever. Ann Surg 1975, 181:88-91.
82. Khosla SN Changing patterns of typhoid (a reappraisal). Asian Med J 1982, 25:185-198.
83. Hoffman SL, Punjabi NH, Kumala S Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 1984, 310:82-88.
84. Punjabi NH, Hoffman SL, Edman DC, et al. Treatment of severe typhoid fever in children with high dose dexamethasone. Pediatr Infect Dis J 1988, 7:598-600.
85. Osuntokun BO, Bademosi O, Ogunremi K, et al. Neuropsychiatric manifestations of typhoid fever in 959 patients. Arch Neurol 1972, 27:7-13.
86. Woodward TE, Smadel JE Management of typhoid fever and its complications. Ann Intern Med 1964, 60:144-157.
87. Rowland HAK The complications of typhoid fever. Am J Trop Med Hyg 1961, 64:143-148.
88. Butler T, Rumans L, Arnold K Response of typhoid fever caused by chloramphenicol-susceptible and chloramphenicol-resistant strains of Salmonella typhi to treatment with trimethoprim-sulfamethoxazole. Rev Infect Dis 1982, 4:551-561.
89. Hoffman SL, Flanigan TP, Klaucke D, et al. The Widal slide agglutination test, a valuable rapid diagnostic test in typhoid fever patients at the Infectious Diseases Hospital of Jakarta. Am J Epidemiol 1986, 123:869-875.
90. Gilman RH, Terminel M, Levine MM, et al. Relative efficacy of blood, urine, rectal swab, bone-marrow and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet 1975, 1:1211-1213.
91. Wicks ACB, Holmes GS, Davidson L Endemic typhoid fever: A diagnostic pitfall. QJM 1971, 40:341-354.
92. Hoffman SL, Punjabi NH, Rockhill RC, et al. Duodenal string-capsule culture compared with bone-marrow, blood, and rectal-swab cultures for diagnosing typhoid and paratyphoid fever. J Infect Dis 1984, 149:157-161.
93. Hoffman SL, Edman DC, Punjabi NH, et al. Bone marrow aspirate culture superior to streptokinase clot culture and 8 ml 1:10 blood-tobroth ratio blood culture for diagnosis of typhoid fever. Am J Trop Med Hyg 1986, 35:836-869.
94. Rubin FA, McWhirter PD, Burr D, et al. Rapid diagnosis of typhoid fever: Identification of Salmonella typhi within 18 hours of specimen acquisition by culture of the mononuclear cell/platelet fraction of blood. J Clin Microbiol 1990, 28:825-827.
95. Rockhill RC, Lesmana M, Moechtar MA, et al. Detection of Salmonella C1, D and V1 antigens, by coagglutination, in blood cultures from patients with Salmonella infection. Southeast Asian J Trop Med Public Health 1980, 11:441-445.
96. Benavente L, Gotuzzo E, Guerra J, et al. Diagnosis of typhoid fever using a string capsule device. Trans R Soc Trop Med Hyg 1984, 78:564-565.
97. Lim PL, Tam FCH, Cheong YM, et al. One-step 2-minute test to detect typhoid-specific antibodies based on particle separation in tubes. J Clin Microbiol 1998, 36:2271-2278.
98. House D, Bishop A, Parry C, et al. Serology of typhoid fever in an area of endemnicity and its relevance to diagnosis. J Clin Microbiol 2001, 39:1002-1007.
99. Hatta M, Goris MG, Heerkens E, et al. Simple dipstick assay for the detection of Salmonella typhi-specific IgM antibodies and the evolution of the immune response in patients with typhoid fever. Am J Trop Med Hyg 2002, 66:416-421.
100. Gasem MH, Smits HL, Goris MG, et al. Evaluation of a simple and rapid dipstick assay for the diagnosis of typhoid fever. J Med Microbiol 2002, 51:173-177.
101. Rubin FA, Kopecko DJ, Sack RB, et al. Evaluation of a DNA probe for identifying Salmonella typhi in Peruvian and Indonesian bacterial isolates. J Infect Dis 1988, 157:1051-1053.
102. Rubin FA, McWhirter PD, Punjabi NH, et al. Use of a DNA probe to detect Salmonella typhi in the blood of patients with typhoid fever. J Clin Microbiol 1989, 27:1112-1114.
103. Chaudhry R, Laxmi BV, Nisar N, et al. Standardisation of polymerase chain reaction for the detection of Salmonella typhi in typhoid fever. J Clin Pathol 1997, 50:437-439.
104. Haque A, Ahmed N, Peerzada A, et al. Utility of PCR in diagnosis of problematic cases of typhoid. Jpn J Infect Dis 2001, 54:237-239.
105. Kumar A, Arora V, Bashamboo A, et al. Detection of Salmonella typhi by polymerase chain reaction: Implications in diagnosis of typhoid fever. Infect Genet Evol 2002, 2:107-110.
106. Massi MN, Shirakawa T, Gotoh A, et al. Rapid diagnosis of typhoid fever by PCR assay using one pair of primers from flagellin gene of Salmonella typhi. J Infect Chemother 2003, 9:233-237.
107. Rowland HAK The treatment of typhoid fever. J Trop Med Hyg 1961, 64:101-111.
108. Woodward TE, Hall HE, Dias-Rivera R, et al. Treatment of typhoid fever. II. Control of clinical manifestations with cortisone. Ann Intern Med 1951, 34:10-19.
109. 2003 Report of the Committee on Infectious Diseases 2003, 541-547. American Academy of Pediatrics Red Book, American Academy of Pediatrics, Elk Grove Village, IL, pp 693-694. 26th ed.
110. Parry CM The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 2004, 98:413-422.
111. Renuka K, Kapil A, Kabra SK, et al. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A. Microb Drug Resist 2004, 10:146-153.
112. Chinh NT, Parry CM, Ly NT, et al. A randomized comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 2000, 44:1855-1859.
113. Soe GB, Overturf GD Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev Infect Dis 1987, 9:719-736.
114. Tran TH, Bethell DB, Nguyen TT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995, 20:917-923.
115. Girgis NJ, Butler T, Frenck RW, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999, 43:1441-1444.
116. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002, 347:1770-1782.
117. ThanhPhuong CX, Kneen R, ThanhMai TT, et al: Comparative study of cefixime and ofloxacin for treatment of uncomplicated typhoid fever in Vietnamese children. Third Asia-Pacific Symposium on Typhoid Fever and Other Salmonellosis, Bali, Indonesia, December 8-10, 1997, Abstract T-6, p 79.
118. Muhdoch DA, Banatvaia NA, Bone A, et al. Epidemic ciprofloxacin resistant Salmonella typhi in Tasjikistan. Lancet 1998, 351:339.
119. White NJ, Parry CM The treatment of typhoid fever. Curr Opin Infect Dis 1996, 9:298-302.
120. Alghasham AA, Nahata MC Clinical use of fluoroquinolones in children. Ann Pharmacother 2000, 34:347-359.
121. Pegues DA, Ohl ME, Miller SI Principles and Practices of Infectious Diseases 2005, 2636-2654. Churchill Livingstone, New York, Salmonella species including Salmonella Typhi. G.L. Mandell, J.E. Bennet, R. Dolin (Eds.).
122. Herzog CH New trends in the chemotherapy of typhoid fever. Acta Trop 1980, 37:275-280.
123. Cao XT, Kneen R, Nguyen TA, et al. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. Pediatr Infect Dis J 1999, 18:245-248.
124. Jones K, Felmingham D, Ridgeway G In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens. Drugs Exp Clin Res 1988, 14:613-615.
125. Metchok B In vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi. J Antimicrob Chemother 1990, 25(Suppl A):29-31.
126. Frenck WF, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000, 31:1134-1138.
127. McGowan JE, Chesney PJ, Crossley KB, et al. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J Infect Dis 1992, 165:1-13.
128. Gotuzzo E, Carillo C Quinolones in typhoid fever. Infect Dis Clin Pract 1994, 3:345-351.
129. Freerksen E, Rosenfeld M, Freerksen R, et al. Treatment of chronic Salmonella carriers. Chemotherapy 1977, 23:192-210.
130. Rodriguez-Noriega E, Andrade-Villanueva J, Amaya-Tapia G Quinolones in the treatment of Salmonella carriers. Rev Infect Dis 1989, 11:S1179-S1187.
131. Beran J, Chlibek R, Weber F A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults. Vaccine 2003, 21:4650-4654.
132. Levine MM, Taylor DN, Fenereccio C Typhoid vaccines come of age. Pediatr Infect Dis J 1989, 8:374-381.
133. Murphy JR, Grez L, Schlesinger L, et al. Immunogenicity of S. typhi Ty21a vaccine for young children. Infect Immun 1991, 59:4291-4293.
134. Yang HH, Kilgore PE, Yang LH, et al. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: Estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J Infect Dis 2001, 183:1775-1780.
135. Robbins JD, Robbins JB Re-examination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 1984, 150:436-449.
136. Keitel WA, Bond NL, Zahradnik JM, et al. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi polysaccharide vaccines. Vaccine 1994, 12:195-199.
137. Ivanoff B, Levine MM, Lambert PH Vaccination against typhoid fever: Present status. Bull World Health Org 1994, 72:957-971.
138. Engels EA, Falagas ME, Lau J, et al. Typhoid fever vaccines: A metaanalysis of studies on efficacy and toxicity. BMJ 1998, 316:110-116.
139. Szu SC, Stone AL, Robbins JD, et al. Vi capsular polysaccharideprotein conjugates for prevention of typhoid fever: Preparation, characterization, and immunogenicity in laboratory animals. J Exp Med 1987, 166:1510-1524.
140. Kossaczka Z, Lin FY, Ho VA, et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun 1999, 67:5806-5810.